ArticleExperimental biology and medicine (Maywood, N.J.)2024
CDKL3 is a promising biomarker for diagnosis and prognosis prediction in patients with hepatocellular carcinoma.
Qingsi Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.